Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients

Hossein Moravej1,2, Ruqaiah Altassan3, Jaak Jaeken4

  • 1Neonatal Research Center Shiraz University of Medical Sciences Shiraz Iran.

JIMD Reports
|February 20, 2020
PubMed
Abstract

Insights

Hypoglycemia is rare in Phosphomannomutase 2 deficiency (PMM2-CDG), but diazoxide effectively treats associated hyperinsulinism. Further research is needed to understand hypoglycemia

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Phosphomannomutase 2 deficiency (PMM2-CDG) is the most common congenital disorder of glycosylation.
  • Hypoglycemia is a known complication in CDGs, but its occurrence and causes in PMM2-CDG are not well understood.

Purpose of the Study:

  • To investigate the frequency and etiology of hypoglycemia in PMM2-CDG patients.
  • To evaluate the efficacy of diazoxide treatment for hyperinsulinism in this population.

Main Methods:

  • Systematic literature review of confirmed PMM2-CDG patients with hypoglycemia.
  • Prospective follow-up of patients treated with diazoxide.

Main Results:

  • Hypoglycemia was reported in only 2.5% of 933 PMM2-CDG patients.
  • Hyperinsulinism was identified in 43% of hypoglycemic patients, with 70% responding well to diazoxide therapy.
  • Long-term diazoxide treatment was often necessary to maintain normoglycemia.

Conclusions:

  • Hypoglycemia is an infrequent but significant finding in PMM2-CDG.
  • Diazoxide-responsive hyperinsulinism has a favorable prognosis with medication.
  • Further prospective studies are warranted to explore underdiagnosis of hypoglycemia and its link to hyperinsulinism in PMM2-CDG.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
730
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
589
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K